Your Article Summary
See Latest ArticlesNifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation
Biochemical and Biophysical Research Communications, 06/16/09
Matsui T et al. - The authors present study provides a unique beneficial aspect of nifedipine on diabetic nephropathy; it could work as an anti-inflammatory agent against AGE by suppressing RAGE expression in cultured mesangial cells via PPAR-gamma activation.
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Eosinophil Count Is Positively Correlated with Albumin Excretion Rate in Men with Type 2 Diabetes
Clinical Journal of the American Society of Nephrology, 11/05/09
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Journal of the American Society of Nephrology, 11/20/09
Today in Nephropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy
Annals of Internal Medicine, 11/03/09
Eosinophil Count Is Positively Correlated with Albumin Excretion Rate in Men with Type 2 Diabetes
Clinical Journal of the American Society of Nephrology, 11/05/09
Renal artery stenosis: pathophysiology and treatment
Expert Review of Cardiovascular Therapy , 11/18/09